Javascript is disabled

Javascript seems to be disabled. This will break some core site features. Please enable javascript or revisit this site from another device.

 

 

Arvid Carlsson

Born 1923, Uppsala, Sweden. Childhood and early adult life, Lund, Sweden. Entered Medical School, Lund University 1941. Started research in pharmacology 1944. MD and PhD 1951. Assistant Professor, pharmacology, Lund 1951, professor, 1956. Clinical education, Department of Internal Medicine, University Hospital, Lund 1954. Professor, pharmacology Gothenburg University 1959-1989. Sabbatical at NIH, USA 1955-56. Nobel Prize in Physiology or Medicine 2000.

The Carlsson team discovered the awakening effect of L-DOPA in reserpine-treated animals (1957) and dopamine in brain as a neurotransmitter (1958), thus laying the ground for the role of dopamine and L-DOPA treatment in Parkinson’s disease and for the concept of chemical neurotransmission in the brain. They proposed that antipsychotics are dopamine-receptor antagonists and introduced the concept of autureceptors in the 1970s, developed the first SSRI, zimelidine (1972) for treatment of depression, the partial dopamine receptor agonist (-)-3-PPP for treatment of psychosis (1982), and in the 1990s and following years, the dopamine stabilizer OSU6162 for the potential use in a variety of disorders, including post-stroke disabilities.

Gunnar Holmgren Honorary Lecture 2017

The Gunnar Holmgren Lecture commemorates Professor Gunnar Holmgren 1875-1954 who is regarded the "father" of Swedish ENT, Head & Neck Surgery. GH started the first Swedish ENT Clinic at Sabbatsbergs Hospital in Stockholm in 1910 and wrote the first Swedish ENT Thesis in 1912. He also developed the microscopic ear surgery technique and founded the Acta Otolaryngologica paper in 1918.


William B Coman AM,

MD MBBS (Qld) FRCS (Edin) FRCS (Eng) FRACS FRCS Hons (Eng) FACS Hons 

Emeritus Professor of Otolaryngology head and neck surgery, The University of Queensland

Chairman and Trustee , Garnett Passe Rodney Williams Memorial Foundation


Professor Coman has a long and outstanding career in ORL Head & Neck Surgery as an internationally well renowned senior Head & Neck Surgeon. To crown his excellent achievements within this field he is the current chairman of the largest ORL-research foundation in Australia the Garnett Passe Rodney Williams Memorial Foundation.

Professor Coman has through his professional dedication and curiosity built a unique international collegial network which also includes Sweden and the Nordic countries. He has recently supported the installation of Anders Cervin from the Department of ORL in Helsingborg/Lund as Professor of ORL in Brisbane and he has hosted several colleges from Sweden at his department at the University of Queensland over the years.

In the clinical field Professor Coman has taken a special interest in head and neck oncology specialising in the USA and Europe as well as in Australia to become one of Australia’s leading Head & Neck Surgeons. Professor Coman has been invited as guest professor to Tianjin Medical University – 2nd Teaching Hospital School Of Medicine, China and as U.S. University Society of Otolaryngology, Head and Neck Surgery 1st Overseas Guest Professor in Washington to mention a few. Professor Coman has received numerous awards, scholarships and honours from different parts of the world for excellence in his work. Professor Coman has served on the editorial boards of several distinguished and well known scientific papers such as the Australian Journal of Otolaryngology, the Laryngoscope and the American Journal of Otolaryngology Head and Neck Medicine and Surgery. Professor Coman has supervised several PhD students and he has published more than 70 scientific articles and book chapters.

Professor William Coman is a frequently invited and well appreciated speaker of Head and Neck Surgery at meetings all over the world. It is a great honour for the NOLF to have Professor Coman as our guest and Gunnar Holmgren Honorary Speaker at the XXXIII Nordic ORL Congress in Gothenburg 2017.

Mary Wells 

Professor of Cancer Nursing Research & Practice, NMAHP Research Unit University of Stirling, UK


Mary is a cancer nurse with a clinical academic background in health services research within oncology. She trained at Guy’s Hospital in London and worked in clinical, leadership and academic posts in London, Oxford and Dundee before moving to her current post in 2013. She is now Professor of Cancer Nursing Research and Practice at the Nursing, Midwifery and Allied Health Professions Research Unit at the University of Stirling. Mary’s research is mainly focussed on the supportive care of people with cancer and in particular the needs, experiences and outcomes of people who have completed treatment. She has always had a particular interest in head and neck cancer since working as a staff nurse on an ENT ward after she first qualified. 

Mary works closely with a number of cancer charities with a major interest in improving experiences, outcomes and cancer care practice. She was a member of the Executive Board of the European Oncology Nursing Society (EONS) from 2009 – 2015 (and Secretary from 2011-2015) and she is currently co-chair of the EONS Research Working Group. Since 2009 she has been a Specialist Advisor to the leading cancer charity Macmillan Cancer Support and the Consequences of Cancer Treatment Collaborative and she is on the Clinical Advisory Board of the Throat Cancer Foundation. In 2016 Mary was appointed as a Trustee of HealthTalk (previously DiPeX). She has been a member of the NCRI Psychosocial Oncology and Survivorship Clinical Studies Group (CSG) since 2013 and has led the Interventions sub-group since 2015. She is also a member of the survivorship sub-group of the Head & Neck CSG. 


Anders Ekholm 

Deputy Director

Anders Ekholm has broad experience from the Government Offices where he worked with quantitative economics and has been the Chief analyst on ministry of health and social affairs but also worked at Swedish Ministry of Finance, Ministry of Employment and Ministry of Education. He has worked with development and analysis of micro-simulation models, including SESIM model where 300,000 statistically representative individuals live simulated life, demography, health, employment, education, taxes and transfers. 

Anders has also worked as an IT project manager, eg for the system state budgets, distributes and monitors the state budget. He is also a frequent speaker hired for inspiration and new solutions in different sectors of society.

https://www.dagensmedicin.se/artiklar/2017/04/27/han-vill-legitimera-patienterna/

Claes Möller

MD, PhD

Professor Möller has a long standing career in ORL and Audiology. He is at present professor at Örebro University and Head at the Audiological Research Centre, University Hospital, Örebro.

Professor Möller has been engaged in various fields of ORL such as otoneurology, pediatrics, audiology with a focus on hereditary hearing loss and its syndromes. Together with geneticists in USA, he was first to clinically and genetically determine different types of the most common syndromal deafness; Usher syndrome – a deafblind disorder. This research has been ongoing for 30 years and as a result, the Swedish Usher data base today has 450 patients. The Usher research has, produced several thesis and at present interdisciplinary research with a focus in other syndromes as well. In recent years, the research has also been focused on cognitive hearing science in cooperation with researchers in Linköping University and the Swedish Institute for Disability Research.

Professor Möller has more than 200 publications in international journals, 25 book chapters and some 1000 scientific presentations. Professor Möller is at present Chair of the council of The International Journal of Audiology and Board member of the Swedish Association for Otorhinolaryngology, Head & Neck Surgery